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INTRODUCTION
Tissue engineering is a multidisciplinary area of research,
which aims to regenerate damaged tissues and organs in the
human body. The general principle is to isolate cells from a
patient who requires a transplant and subsequent culturing
of the cells on a suitable support to produce the replacement
tissue. On the one hand, it is necessary to find a suitable
support on which cells can adhere and form stratified struc-
tures. On the other hand, the conditions allowing cells to
proliferate and differentiate into various types of tissues
must be understood and reproduced. At present, there are
various materials used as support in the treatment of ulcers
and burns (Negri et al., 2009).
Full-thickness skin defects caused by burns, soft tissue
trauma and diseases leading to skin necrosis represent im-
portant clinical problems that are far from being solved. The
main challenges are: 1) donor site shortage for autologous
skin transplantation when the defect exceeds 50–60% of the
total body surface area (a typical clinical example is a mas-
sive deep burn), and 2) most conventional skin grafting
techniques to provide autologous defect coverage are based
on transplanting split-thickness skin (Bottcher-Haberzeth et
al., 2010).
The main goals of skin tissue engineering are healing and
complete simulation of physiological skin, with close to na-
tive mechanical qualities, and lack of recipient toxicity or
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The most common reasons for major skin loss are thermal trauma — burns and scalds that can
result in rapid, extensive, deep wounds as well as chronic non-healing wounds. Treatment using
common techniques is poor and depending on the trauma level can result in death. There is a
substantial need for skin integrity restoration. The main goal of this study was to develop an
autologous 3D skin model that could eventually be translated into clinical applications. The study
examined a variety of factors — extracellular matrix components, cell count, culture medium mod-
ification and role of structurally and functionally high-quality 3D skin dermis layer tissue culture
production. The results of this study are an essential prerequisite to standardise the use of both
clinical, as well as in vitro test systems. Dermal cell lines applied in the study were isolated form
patient biopsies obtained at Pauls Stradiòð Clinical University Hospital. Blood plasma type AB
was used for fibrin matrix formation. As catalysts, CaCl2 or calcium gluconate, and tranexamic
acid were applied. 3D tissue functionality was assessed by evaluation of gene expression and
changes in growth factor secretion. Fibrin matrix formulations with 1% and 1.5% CaCl2 and 5 mg,
7 mg and 10 mg tranexamic acid concentration were tested. Better matrix properties were ob-
served with higher concentration of CaCl2 and tranexamic acid. Differences in levels of collagen
gene expression and growth factor secretion were observed. Changes in levels of fibroblast
growth factor and gene expression were observed in fibrin matrix samples and the sur-
face-cultivated cell culture monolayer, but structural protein synthesis was not detected.
Key words: autologous skin model, in vitro bioengineering, 3D skin cultivation.
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immune rejection (Boyce et al., 2001). In addition, the res-
toration of skin anatomy needs to go beyond rehabilitation
of structural architecture and needs to include skin pigmen-
tation, nerve, vascular plexus, and adnexa reinstitution. The
design of artificial skin substitutes also needs to consider
the genotype of the transplanted skin cells, the biocompati-
bility of materials applied and the complexity of fabrication
(Boyce et al., 1996). The restoration of an intact barrier and
prevention of sepsis are crucial in skin regeneration treat-
ment, particularly in cases of large burns. Another impor-
tant goal is the initiation of healing processes in the case of
chronic wounds. The basic aspects for the design of artifi-
cial skin need consideration of physicochemical, biochemi-
cal and mechanical features (Yannas and Burke, 1980). Be-
sides the issues mentioned above, an artificial skin
transplant should control fluid regulation, avoid infection,
promote contracture and scarification.
There are multiple potential approaches to improving skin
regeneration. These include the choice of the type of cells,
their source and cell processing during fabrication of the
skin transplant. Future research should focus on how to de-
crease the risks of disease transmission in patients receiving
artificial skin grafts. Additional research on the molecular
basis of scar wound healing and simulation of scarless heal-
ing will continue to contribute to skin graft fabrication
strategies (Bottcher-Haberzeth et al., 2010).
The aim of this study was to evaluate properties of autolo-
gous fibrin-based cell cultivation matrix.
MATERIALS AND METHODS
Cell lines. The cell lines D03 and D04 used in this study
were extracted from patient biopsies obtained at Pauls Stra-
diòð Clinical University Hospital. Biopsies were collected
from post-operative material, average sample size — 0.5–2
cm2. The study utilised the passage p0-9. Human cell lines
were obtained in accordance with Latvian legislation and
the Helsinki Declaration.
Fibrin matrix preparation. Fibrin matrix formation was
performed according to the protocol of Negri et al. (2009).
CaCl2 or calcium gluconate was used as a catalyst and
tranexamic acid was used as an anti-fibrinolytics agent. The
AB type plasma used for matrix formation was received
from Pauls Stradiòð Clinical University Hospital blood
preparation department.
Cell cultivation in 3D fibrin matrix. Dermal cell lines
D03 and D04 were cultured in fibrin matrix. Matrix formu-
lations containing CaCl2 (1% and 1.5%) and tranexamic
acid (5 mg, 7 mg, 10 mg) were tested. Samples were differ-
entially dyed by two methods: 1) hematoxylin and eosin
(H&E) and 2) Masson’s trichrome (TR) stain method.
Analysis of gene expression. Samples of cells from cul-
tures were collected at days 7 and 21. RNA was isolated
and cDNA was used for qPCR assay.
Changes in gene Col1A1, MMP-1, FGF2, FGF7, EGF,
FGFR1 expression were evaluated against quantity of
PGK1 mRNA.
Changes in gene expression were compared between 3D
matrix culture samples and the cell lines cultured on artifi-
cial surface.
In vivo skin gene expression was compared to in vitro cul-
tured samples. RNA from skin samples was isolated and
Col1A1, FGF2 and FGF7 gene expression of dermis was
quantified against PGK1 mRNA volume.
Analysis of growth factor synthesis dynamics. Growth
factor analysis was carried out by ELISA assay, protein
FGF2 and FGF7 levels were detected in 3D fibrin matrix
culture media supernatant as well as on the surface of cul-
tured cell culture media supernatants at days 7 and 21. The
S10 culture medium supernatant from samples with a fibrin
matrix without cells was used as a control.
RESULTS
Cell cultivation in 3d fibrin matrix. Dermal fibroblast cell
lines obtained from two skin biopsies were cultured in fi-
brin matrix. Matrix formulations containing CaCl2 (1% and
1.5%) and tranexamic acid (5 mg, 7 mg, 10 mg) concentra-
tion were applied. All combinations of components of ma-
trix resulted in full polymerisation and cell culturing was
successfully carried out. Cells cultured in a monolayer on
plastic surfaces and 3D fibrin matrix (Fig. 1) showed differ-
ences in cell morphology. Both cell lines had uniform cell
distribution in the matrix, forming a multilayer structure.
After seven days of culturing, both cell lines show
fibroblasts with characteristic spindle and star-shaped cell
morphology for all matrix cells (Fig. 2, A, B), but after cul-
turing cells for 21 days, cell morphology changed — the
cells along the top edge of the matrix had a cubic shape that
resembled epithelial layer cells (Fig. 2, C, D).
Samples were dyed by hematoxylin/eosin and Masson’s
trichrome method. Eosin and hematoxylin stain dyed sam-
ples showed the above changes in cell morphology at seven
and 21 days. A change in the colour of Masson’s trichrome
stain was observed in samples from cell line D04 after culti-
vation for 21 days in fibrin matrix with 1.5% CaCl2, and 10
mg tranexamic acid. A blue tint indicated possible presence
of collagen in the extracellular matrix, but it is impossible
to determine the fibre composition using a single differen-
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Fig. 1. Cell line D04 morphology cultivated on surface (A) or in 3D fibrin
matrix (B). Scale corresponds to 100 µm
tial staining method. In the D03 cell line samples this differ-
ence was not observed.
Comparison of matrix formulations shows that CaCl2 and
tranexamic acid concentrations affected both matrix physi-
cal properties like cell proliferation and availability of test-
ing. Cell proliferation takes place at a higher CaCl2 and
tranexamic acid concentration, because at lower component
concentrations matrix consistency is too liquid; and by in-
fluence of gravity most of cells are relocated towards matrix
bottom layers. For this reason, 1.5% CaCl2, 7 and 10 mg
tranexamic acid concentrations were used for further matrix
formulations.
Analysis of gene expression. Gene expression was evalu-
ated in 3D and 2D cultured cells. Samples of cells were col-
lected at days 7 and 21. Changes in gene Col1A1, MMP-1,
FGF2, FGF7, EGF, FGFR1 expression were evaluated
against quantity of PGK1 mRNA. No changes were found
in gene MMP-1, EGF and FGFR1 expression, and therefore
testing of expression of these genes was excluded from fur-
ther analysis.
Differences in gene expression were observed between cell
lines for genes Col1A1, FGF2 and FGF7 (see Figs. 3 and
4).
Col1A1 gene expression increased after seven days com-
pared to 2D cultured cells, which was observed only in cell
line D04 at 7 mg tranexamic acid concentration. After 21
days of cultivation changes had occurred in D4 cell line at
both tranexamic acid concentrations. In the cell D03 line at
7 mg tranexamic acid concentration, Col1A1 gene expres-
sion was five times higher than in the control. At day 7,
FGF2 gene expression had increased by ten and twenty
times in samples with the 7 mg and 10 mg tranexamic acid
concentration, respectively. Cell line D04 gene expression
level was lower than the surface cultured cells at day 7.
However, at day 21, the cell line D3 FGF2 gene expression
had decreased, while the D04 cell line at 10 mg tranexamic
acid concentration had a tenfold increase in the expression
of this gene. Changes of FGF7 gene expression were simi-
lar to that for the FGF2 gene: at day 7, FGF7 expression
had significantly increased in cell line D03 in both tranex-
amic acid concentrations and decreased expression in cell
line D4, but on day 21, gene expression had decreased in
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Fig. 2. Dermal cells cultivated in 3D fibrin matrix. A, day 7, cell line D03,
H&E; B, day 7, cell line D03, TR; C, day 21, cell line D04, E&H; D,
day21, cell line D04, TR. Scale corresponds to 100 µm.
Fig. 3. Relative gene expression changes between cultivating cells for 7
days in 3D fibrin matrix with different tranexamic acid concentration and
2D. A, B and C – cell line D03; D, E and F – cell line D04.
Fig. 4. Relative gene expression of cultivating cells at 21 days in 3D fibrin
matrix with different tranexamic acid concentration and 2D. A, B and C –
cell line D03; D, E and F – cell line D04.
the D03 line, while for the D04 cell line at 7 mg tranexamic
acid concentration, FGF7 gene expression was slightly
above the level of the control.
Dermis gene expression was also compared to that of cul-
tured cell samples. Col1A1, FGF2 and FGF7 gene expres-
sion were determined. Table 1 shows changes in gene ex-
pression of 3D matrix cultured cells in comparison with 2D
cultured cells and derma.
At day 7, gene expression of Col1A1 in cell line D03 was
lower than in both 2D cultured cells and derma, FGF2 ex-
pression was generally high, and was even 50 000% higher
in cell line DO3 than in the derma sample at 10 mg tranex-
amic acid concentration. Similarly, gene FGF7 expression
was more than 200 000% higher in cell line DO3 at 10 mg
tranexamic acid concentration than in normal dermis. At
day 21, in cell line D3 Col1A1 expression was higher than
in 2D cultured cells and lower than in in derma. FGF2 and
FGF7 expression was lower cell line D3 than in 2D cul-
tured cells, and more than 200 000% higher than in derma
at tranexamic acid concentration 7 mg.
On day 7, Col1A1 gene expression was higher in cell line
D4 than in both 2D cultured cells and derma, but in FGF2
such increases are seen in comparison to the dermis of the
sample with 7 mg tranexamic acid concentration. GFF7
gene expression was lower in cell line D4 than in 2D cul-
tured cells expression but 400 000% higher than in dermis.
On day 21, in cell line D4, Col1A1 gene expression was
slightly higher than in 2D cultured cells, but lower than in
derma. FGF2 expression at both tranexamic acid concentra-
tions was higher in in cell line D4 than in 2D cultured cells
and derma by several hundred per cent, while FGF7 gene
expression in cell line D4 was significantly higher by more
than 6000% and 2000% for derma at 7 mg and 10 mg
tranexamic acid concentration, respectively.
Analysis of growth factor synthesis dynamics. ELISA as-
says were used to determine protein FGF2 and FGF7 levels
in 3D fibrin matrix and on surface cultivated cell culture
media supernatant days 7 and 21. FGF2 and FGF7 protein
concentrations are shown in Figure 5.
None of the cell line samples showed significant secretion
of FGF2 protein compared to the control samples and culti-
vated 2D cultures. Maximum FGF7 protein concentration of
774 pg/ml was reached on day 7 in samples with tranexamic
acid concentration 7 mg, the level fell to 674 pg/ml on day
21. Such a trend is observed in samples with tranexamic
acid concentration of 10 mg, but throughout the cultivation
period, the protein concentration is higher than in the con-
trol. Control samples of polymerized fibrin matrix without
cells showed the presence of FGF7 and FGF2 protein, indi-
cating that plasma contains a certain level of growth factors.
DISCUSSION
This study showed that it is possible to create a 3D dermis
cell culture model using easily available materials at low
cost — plasma, CaCl2, tranexamic acid and saline. Compat-
ibility of different fibrin matrix components was evaluated.
In general, all variants of the experiment were successful, as
plasma polymerised and 3D matrix was formed. Various
publications describe methods of forming matrix using
CaCl2 (1% and 1.5%) and tranexamic acid (5–10 mg) poly-
merisation (Negri et al., 2009). Minor differences were ob-
served in the physical properties of the matrix; matrix struc-
ture was more liquid at lower concentrations of CaCl2 and
tranexamic acid, where cells tended to sediment and physi-
cal properties of matrix did not allow to move it without
breaking matrix layer. This could be caused by lack of
tranexamic acid, which can lead to insufficient inhibition of
plasminogen activation and occurrence of slight fibrinolytic
activity. Higher CaCl2 and tranexamic acid concentrations
of the matrix resulted in increase of stiffness and density.
Prolonged cell culturing (three weeks) resulted in changes
of morphology of upper matrix layer cells, which began to
resemble epithelial layer cells. It should be noted that der-
mal matrix was cultured covered with medium, so in this
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Table 1. Gene expression of cells cultivated in 3D fibrin matrix in compar-
ison to 2D cultivated cells and dermis. 1, cell line; 2, cultivation time;
3, tranexamic acid concentration
1 2 3 Col1A1 FGF2 FGF7
D03 7days 7mg compared to 2D   10x  10x
compared to dermis    10x
10mg compared to 2D   20x  20x
compared to dermis   5000x  2000x
21days 7mg compared to 2D   
compared to dermis   3000x  2000x
10mg compared to 2D   
compared to dermis   30x  10x
D04 7days 7mg compared to 2D   
compared to dermis  70x  700x  400x
10mg compared to 2D   
compared to dermis   20x  10x
21days 7mg compared to 2D   
compared to dermis   20x  70x
10mg compared to 2D   10x 
compared to dermis   70x  20x
Fig. 5. FGF2 and FGF7 protein concentrations after 7 and 21 days of culti-
vating cell line D04 in 3D fibrin matrix with different tranexamic acid con-
centrations.
case the cell morphology changes could not be initiated by
air/matrix surface exposition, which is the precondition for
epidermal cell culture stratification (Bernstam et al., 1986).
Histological dying with Masson’s trichrome for cell line
D04 at day 21 day for samples cultivated in matrix with
1.5% CaCl2 and 10 mg tranexamic acid showed potential
collagen presence in matrix, indicating a possible late colla-
gen synthesis initiation. Collagen deposition in extracellular
matrix can be initiated at different cultivation times accord-
ing to cell line specification. This might be related to a spe-
cific matrix shrinkage both in a vertical and a horizontal
plane, which is a typical, but undesirable process. This phe-
nomenon is caused by fibroblast differentiation into miofi-
broblasts, which normally takes place during wound heal-
ing. It ensures wound surface reduction and tightening of
tissues without cell migration (Harrison and MacNeil,
2008).
Both the analysis of gene expression and secretion of
growth factors showed differences between the cell lines,
which indicates that a cell line choice for 3D tissue culture
model design is essential. This must be taken into account
for further optimisation and evaluation of the matrix com-
ponent concentration and cultivation time effects on tissue-
culture functionality. Since the current results showed con-
trasting results, such as for FGF7 gene expression in the
tested cell lines, work should be continued, and gene ex-
pression and protein secretion should be assessed in vast
number of different cell lines. There is a need for more de-
tailed characterisation of cell cultures before the use for tis-
sue culture model design — growth factor and structural
protein gene expression profile characterisation should be
firstly applied. Potential application of dermal/epidermal
3D cultures as model systems or as skin substitute trans-
plants requires knowledge of critical control points for
growth factor expression and secretion. For example, a skin
substitute transplant will be ineffective if using cell line
with low or insufficient secretion of growth factors needed
for wound healing processes. Also, it is important to assess
whether a too high expression level of a certain growth fac-
tor might result in adverse effects after tissue culture clini-
cal application.
Overall, the data on gene expression showed that collagen
synthesis is reduced and delayed, which is also consistent
with the results obtained by histological cut staining, espe-
cially compared to the collagen I gene expression, which is
observed in postoperative obtained dermis material. This
should be not viewed negatively in the case of clinical ap-
plication, as fibrin matrix provides surface cell adhesion,
migration, proliferation and forms a sufficiently flexible,
physical and functional structure that can benefit wound
healing and skin integrity restoration. Collagen synthesis
might be delayed due to migration and division of cells. But
this do not benefit experimental tissue models that are used
in a variety of tissue functionality studies where the pres-
ence of structural proteins is very important, because these
models have to imitate the in vivo structures more accu-
rately.
The data on fibroblast growth factor gene expression
showed higher FGF2 and FGF7 gene expression during cell
culturing in the matrix compared to the dermis obtained
from postoperative material, but different results were ob-
served compared to cells cultured in 2D. Such differences
suggest changes in cell functional status by cultivating them
in a different environment, shown by differences in growth
factor secretion, gene expression and protein secretion by
the ELISA analysis. Culture media supernatant was used for
analysis, but as it is unknown if the growth factors are bind-
ing to matrix, so it is unclear if all secreted growth factors
were presented in culture media.
Cell cultivation in fibrin matrix simulates skin as a struc-
ture, and in processes of regeneration and wound healing,
and in proliferation phases of reconstruction. Increased fi-
broblast growth factor expression is characteristic for
wound healing (Komi-Kuramochi et al., 2005). Fibroblast
growth factors promote tissue repair in vivo and also pro-
mote and improve tissue engineering forming a skin model
quality and functional state (Erdag and Morgan, 2004).
There is clear need to conduct further experiments on culti-
vation of fibrin matrix with existing and additional donor
cell lines to obtain a sufficient data set related to patient
specific factors that can influence gene and growth factor
expression during cell cultivation (Pillet et al., 2017; Chung
et al., 2016). Further studies should be addressed to evalu-
ate advantages and disadvantages of cell culture, cell cultur-
ing in other types of matrix (biodegradable synthetic poly-
mers and collagen matrix), and other growth factor gene
expression profiles, such as VEGF, which is an important
factor in angiogenesis and essential for the production of
autologous skin transplant functionality (Benny et al.,
2016).
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DERMAS AUDU 3D KULTIVÇÐANA, IZMANTOJOT AUTOLOGU MATRIKSU
Bieþâkais nopietnu âdas zudumu iemesls ir termâlâs traumas — apdegumi un apsaldçjumi, kas âtri pârvçrðas ekstensîvâs un dziïâs brûcçs,
tai skaitâ hroniskâs un nedzîstoðâs brûcçs. Ðobrîd pieejamâs terapijas iespçjas ir ierobeþotas un nesniedz nepiecieðamo risinâjumu. Tâpçc ir
nepiecieðami jauni risinâjumi âdas integritâtes atjaunoðanai. Pçtîjuma galvenais mçríis ir izveidot autologu 3D âdas modeli, kuru bûtu
iespçjams pielietot jaunu medicînas tehnoloìiju izstrâdç. Pçtîjuma gaitâ tika novçrtçta daþâdu faktoru — ekstracelulârâ matriksa
komponenðu, ðûnu skaita, kultivçðanas vides ietekmi uz strukturâli un funkcionâli kvalitatîva 3D dermas slâòa izveidoðanu. Pçtîjuma gaitâ
izmantotâs dermas ðûnu lînijas tika izdalîtas no pacientu biopsijâm, kas tika iegûtas Paula Stradiòa Klîniskajâ universitâtes slimnîcâ. Fibrîna
matriksa veidoðanai tika izmantota AB tipa asins plazma. Fibrîna matrikss tika izgatavots, kâ katalizatoru izmantojot CaCl2 vai kalcija
glukonâtu un/vai traneksâm skâbi. 3D dermas slâòa funkcionalitâte tika novçrtçta, salîdzinot gçnu ekspresijas un augðanas faktoru
izdalîðanâs izmaiòas. Pçtîjuma gaitâ tika izgatavoti 3D dermas slâòa paraugi, matriksa veidoðanai izmantojot 1% un 1.5% CaCl2 un 5 mg,
7 mg un 10 mg traneksânskâbes koncentrâciju. Labâkas matriksa funkcionâlâs îpaðîbas tika novçrotas, izmantojot augstâkâs CaCl2 un
traneksânskâbes koncentrâcijas. Tika novçrotas izmaiòas kolagçna gçnu ekspresijas un augðanas faktoru sekrçcijas lîmenî. Salîdzinot
fibrîna matriksa paraugus ar monoslânî audzçtâm ðûnu kultûrâm, tika novçrota paaugstinâta fibroblastu augðanas faktora sekrçcija un gçnu
ekspresija, bet strukturâlo proteînu sintçze netika novçrota.
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